164 related articles for article (PubMed ID: 29232844)
1. Protection of Mice from Lethal Vaccinia Virus Infection by Vaccinia Virus Protein Subunits with a CpG Adjuvant.
Reeman S; Gates AJ; Pulford DJ; Krieg A; Ulaeto DO
Viruses; 2017 Dec; 9(12):. PubMed ID: 29232844
[TBL] [Abstract][Full Text] [Related]
2. A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost.
Xiao Y; Aldaz-Carroll L; Ortiz AM; Whitbeck JC; Alexander E; Lou H; Davis HL; Braciale TJ; Eisenberg RJ; Cohen GH; Isaacs SN
Vaccine; 2007 Jan; 25(7):1214-24. PubMed ID: 17098336
[TBL] [Abstract][Full Text] [Related]
3. A Nucleic Acid-Based Orthopoxvirus Vaccine Targeting the Vaccinia Virus L1, A27, B5, and A33 Proteins Protects Rabbits against Lethal Rabbitpox Virus Aerosol Challenge.
Mucker EM; Golden JW; Hammerbeck CD; Kishimori JM; Royals M; Joselyn MD; Ballantyne J; Nalca A; Hooper JW
J Virol; 2022 Feb; 96(3):e0150421. PubMed ID: 34851148
[TBL] [Abstract][Full Text] [Related]
4. Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions.
Fogg C; Lustig S; Whitbeck JC; Eisenberg RJ; Cohen GH; Moss B
J Virol; 2004 Oct; 78(19):10230-7. PubMed ID: 15367588
[TBL] [Abstract][Full Text] [Related]
5. Short-term and longer-term protective immune responses generated by subunit vaccination with smallpox A33, B5, L1 or A27 proteins adjuvanted with aluminum hydroxide and CpG in mice challenged with vaccinia virus.
Xiao Y; Zeng Y; Schante C; Joshi SB; Buchman GW; Volkin DB; Middaugh CR; Isaacs SN
Vaccine; 2020 Aug; 38(38):6007-6018. PubMed ID: 32741672
[TBL] [Abstract][Full Text] [Related]
6. Adsorption of recombinant poxvirus L1-protein to aluminum hydroxide/CpG vaccine adjuvants enhances immune responses and protection of mice from vaccinia virus challenge.
Xiao Y; Zeng Y; Alexander E; Mehta S; Joshi SB; Buchman GW; Volkin DB; Middaugh CR; Isaacs SN
Vaccine; 2013 Jan; 31(2):319-26. PubMed ID: 23153450
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges.
Fogg CN; Americo JL; Lustig S; Huggins JW; Smith SK; Damon I; Resch W; Earl PL; Klinman DM; Moss B
Vaccine; 2007 Apr; 25(15):2787-99. PubMed ID: 17229505
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of CD8+ T cell immunity in the lung by CpG oligodeoxynucleotides increases protective efficacy of a modified vaccinia Ankara vaccine against lethal poxvirus infection even in a CD4-deficient host.
Belyakov IM; Isakov D; Zhu Q; Dzutsev A; Klinman D; Berzofsky JA
J Immunol; 2006 Nov; 177(9):6336-43. PubMed ID: 17056564
[TBL] [Abstract][Full Text] [Related]
9. Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response.
Paran N; Lustig S; Zvi A; Erez N; Israely T; Melamed S; Politi B; Ben-Nathan D; Schneider P; Lachmi B; Israeli O; Stein D; Levin R; Olshevsky U
Virol J; 2013 Jul; 10():229. PubMed ID: 23842430
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
[TBL] [Abstract][Full Text] [Related]
11. Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease.
Golden JW; Zaitseva M; Kapnick S; Fisher RW; Mikolajczyk MG; Ballantyne J; Golding H; Hooper JW
Virol J; 2011 Sep; 8():441. PubMed ID: 21933385
[TBL] [Abstract][Full Text] [Related]
12. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host.
Fang M; Cheng H; Dai Z; Bu Z; Sigal LJ
Virology; 2006 Feb; 345(1):231-43. PubMed ID: 16256161
[TBL] [Abstract][Full Text] [Related]
13. A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge.
Buchman GW; Cohen ME; Xiao Y; Richardson-Harman N; Silvera P; DeTolla LJ; Davis HL; Eisenberg RJ; Cohen GH; Isaacs SN
Vaccine; 2010 Sep; 28(40):6627-36. PubMed ID: 20659519
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen.
Sakhatskyy P; Wang S; Chou TH; Lu S
Virology; 2006 Nov; 355(2):164-74. PubMed ID: 16919703
[TBL] [Abstract][Full Text] [Related]
15. Maternal antibody induced by recombinant gp85 protein vaccine adjuvanted with CpG-ODN protects against ALV-J early infection in chickens.
Dou W; Li H; Cheng Z; Zhao P; Liu J; Cui Z; Liu H; Jing W; Guo H
Vaccine; 2013 Dec; 31(51):6144-9. PubMed ID: 23831319
[TBL] [Abstract][Full Text] [Related]
16. Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection.
Zhu Q; Talton J; Zhang G; Cunningham T; Wang Z; Waters RC; Kirk J; Eppler B; Klinman DM; Sui Y; Gagnon S; Belyakov IM; Mumper RJ; Berzofsky JA
Nat Med; 2012 Aug; 18(8):1291-6. PubMed ID: 22797811
[TBL] [Abstract][Full Text] [Related]
17. Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge.
Pulford DJ; Gates A; Bridge SH; Robinson JH; Ulaeto D
Vaccine; 2004 Sep; 22(25-26):3358-66. PubMed ID: 15308360
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge.
Martínez O; Bravo Cruz A; Santos S; Ramírez M; Miranda E; Shisler J; Otero M
Vaccine; 2017 Oct; 35(44):6007-6014. PubMed ID: 28629922
[TBL] [Abstract][Full Text] [Related]
19. Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge.
Lustig S; Fogg C; Whitbeck JC; Eisenberg RJ; Cohen GH; Moss B
J Virol; 2005 Nov; 79(21):13454-62. PubMed ID: 16227266
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses induced by recombinant ALV-A gp85 protein vaccine combining with CpG-ODN adjuvant in breeder hens and the protection for their offspring against early infection.
Zhang D; Li H; Zhang Z; Sun S; Cheng Z; Liu J; Zhao P; Ren Q; Guo H
Antiviral Res; 2015 Apr; 116():20-6. PubMed ID: 25637708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
